Researcher
Michel Koole
- Disciplines:Medical imaging and therapy, Medicinal products
Affiliations
- Nuclear Medicine & Molecular Imaging (Division)
Member
From1 Jan 2007 → Today
Projects
1 - 10 of 20
- A whole-body physiologically based pharmacokinetic model for personalized 161Tb-PRRTFrom1 Oct 2023 → TodayFunding: SCK (Study Centre Nuclear Energy)
- '213Bi-188Ready' Improved Theranostics with Bismuth-213 and Rhenium-188From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Fast quantitative SPECT imaging for patient specific dosimetry to facilitate personalized 177Lu-PSMA treatmentFrom18 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- IMAGINATION : IMAGing bIomarkers for diagNosis, therAnosTIcs and drug develOpmeNtFrom1 Oct 2022 → TodayFunding: IOF - mandates
- Low dose, high resolution Ga-68 PET imaging for oncological indicationsFrom25 May 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Innovative concepts for PET-MR imaging of brain function and brain-gut interactionsFrom14 Jan 2022 → TodayFunding: BOF - doctoral mandates
- Modelling of tumor control probability in preclinical targeted radionuclide therapyFrom1 Oct 2021 → TodayFunding: SCK (Study Centre Nuclear Energy)
- 18F-PSMA-1007 PET/MR imaging, quantification and radiomics in the primary staging of prostate cancer and response prediction after neoadjuvant hormonal therapyFrom1 Aug 2021 → TodayFunding: FWO Strategic Basic Research Grant
- "Dosimetry aspects of recoiling daughter nuclides of 225-Actinium in Targeted Alpha Therapy"From8 Nov 2019 → 15 Jul 2022Funding: SCK (Study Centre Nuclear Energy)
- BEyOND: Brain pEt to Overcome Neurodegenerative Diseases.From15 Apr 2019 → 14 Apr 2021Funding: BOF - various
Publications
11 - 20 of 182
- 18F-AlF-NOTA-Octreotide Outperforms 68Ga-DOTATATE/ NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study(2023)
Authors: Elin Pauwels, Frederik Cleeren, Michel Koole, Jeroen Dekervel, Annouschka Laenen, Paul Clement, Chris Verslype, Guy Bormans, Christophe Deroose
Pages: 632 - 638 - Differences in Cerebral Glucose Metabolism in ALS Patients with and without C9orf72 and SOD1 Mutations(2023)
Authors: Joke De Vocht, Fouke Ombelet, Pegah Masrori, Hilde Van Esch, Michel Koole, Patrick Dupont, Koen Van Laere, Philip Van Damme
- [18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patients(2023)
Authors: Sofie Celen, Kristof Baete, Michel Koole, Oliver Bechter, Paul Clement, Koen Van Laere, Guy Bormans, Christophe Deroose
Pages: 1134 - 1145 - EANM guidelines for PET-CT and PET-MR routine quality control(2023)
Authors: Michel Koole
Pages: 103 - 113 - SDI-118, a Novel Procognitive SV2A Modulator: First-in-Human 1 Randomized Controlled Trial Including PET/fMRI Assessment of 2 Target Engagement(2023)
Authors: Michel Koole, Koen Van Laere, Stefan Sunaert
- In Vivo Detection of Neurofibrillary Tangles by 18F-MK-6240 PET/MR in Patients With Ischemic Stroke(2023)
Authors: Stefan Sunaert, Mathieu Vandenbulcke, Guy Bormans, Geert Verheyden, Michel Koole, Koen Van Laere, Robin Lemmens
Pages: E62 - E71 - Multiplex core of the human brain using structural, functional and metabolic connectivity derived from hybrid PET-MR imaging.(2023)
Authors: Koen Van Laere, Michel Koole
Pages: 1115965 - Intra-individual qualitative and quantitative comparison of [68Ga]Ga-DOTATATE PET/CT and PET/MRI(2023)
Authors: Niloefar Ahmadi Bidakhvidi, Annouschka Laenen, Jeroen Dekervel, Chris Verslype, Kristiaan Nackaerts, Paul Clement, Michel Koole, Karolien Goffin, Koen Van Laere, Christophe Deroose
- Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [11C]CHDI-00485180-R and [11C]CHDI-00485626, designed for quantification of cerebral aggregated mutant huntingtin(2022)
Authors: Aline Delva, Michel Koole, Guy Bormans, Wim Vandenberghe, Koen Van Laere
Pages: 48 - 60 - Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study(2022)
Authors: Michel Koole
Pages: 4551 - 4566